MedPath

南京海润医药有限公司

Ownership
-
Established
2010-12-22
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

16

NMPA:16

Drug Approvals

Decitabine

Product Name
地西他滨
Approval Number
国药准字H20130014
Approval Date
May 6, 2022
NMPA

Levobupivacaine Hydrochloride

Product Name
盐酸左布比卡因
Approval Number
国药准字H20123230
Approval Date
Dec 6, 2021
NMPA

Dexrazoxane for Injection

Product Name
注射用右雷佐生
Approval Number
国药准字H20213177
Approval Date
Mar 16, 2021
NMPA

Esomeprazole sodium

Product Name
艾司奥美拉唑钠
Approval Number
国药准字H20163099
Approval Date
Mar 1, 2021
NMPA

Dexrazoxane

Product Name
右雷佐生
Approval Number
国药准字H20060872
Approval Date
Nov 26, 2020
NMPA

Fludarabine Phosphate

Product Name
磷酸氟达拉滨
Approval Number
国药准字H20060905
Approval Date
Nov 26, 2020
NMPA

Nedaplatin

Product Name
奈达铂
Approval Number
国药准字H20051987
Approval Date
Aug 21, 2020
NMPA

Omeprazole Sodium

Product Name
奥美拉唑钠
Approval Number
国药准字H20058021
Approval Date
Aug 21, 2020
NMPA

Oxaliplatin

Product Name
奥沙利铂
Approval Number
国药准字H20051985
Approval Date
Aug 21, 2020
NMPA

Lansoprazole

Product Name
兰索拉唑
Approval Number
国药准字H20103682
Approval Date
Aug 21, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy